Link to this page
Ontology of Cardiovascular Drug Adverse Events
Last uploaded:
December 29, 2016
Jump to:
| Id | http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000008048
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000008048
|
|---|---|
| Preferred Name | Sulfonamides [Chemical/Ingredient] |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| label |
Sulfonamides [Chemical/Ingredient]
|
|---|---|
| prefLabel |
Sulfonamides [Chemical/Ingredient]
|
| NUI |
N0000008048
|
| code |
C26460
|
| prefixIRI |
NDF-RT:N0000008048
|
| RxNorm_CUI |
10215
|
| subClassOf | |
| imported from | |
| MeSH_CUI |
M0020790
|
| MeSH_DUI |
D013449
|
| type | |
| MeSH_Name |
Sulfonamides
|
| UMLS_CUI |
C0038760
|
| Display_Name |
Sulfonamides
|
| MeSH_Definition |
A group of compounds that contain the structure SO2NH2. Members of this group, also known as sulfa drugs, are derivatives of sulfanilamide, which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. They have been largely supplanted by more effective and less toxic antibiotics. (From Dorland, 28th ed)
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |